<br/>
<div class="section far2x" id="outbreak-section">
    <h3 class="close2x section-title"><span class="wrap">Outbreak</span></h3>
    <p style="margin-bottom: 5px;">
        Influenza A subtype H5N1, commonly known as avian influenza or bird flu, has garnered significant attention due
        to its potential to cause severe illness in both birds and humans. Originating primarily in wild birds, H5N1 can
        occasionally infect domestic poultry, posing significant economic and public health concerns. H5N1 infections
        are rare in humans but have been associated with high mortality rates, making it a focus of pandemic
        preparedness efforts. The virus is known for its ability to undergo genetic reassortment & evolve into novel
        strains with pandemic potential. Continuous surveillance and research are crucial for monitoring H5N1 activity,
        understanding its transmission dynamics, and developing effective control measures to mitigate the risk of
        widespread outbreaks.
    </p>
    <div style="display: flex;">
        <div style="margin-right: 10px;">
            <img src="/public/js/p3/resources/images/outbreaks/h5n1/influenza_a_h5n1_hosts.png"
                 style="max-width: 300px"/>
            <blockquote style="text-align: center;max-width: 85%;margin: auto;">
                Currently reported and sequenced hosts infected with H5N1.
            </blockquote>
        </div>
        <div>
            <p style="margin-bottom: 5px;">
                In 2020, highly contagious bird flu (HPAI) A(H5N1) viruses emerged from existing strains. They spread
                mainly through migrating birds across Africa, Asia, and Europe, causing significant wild bird deaths and
                poultry outbreaks. By late 2021, these viruses reached North America and South America in 2022. A recent
                outbreak in a mink farm in Spain has also affected other animals, like mammals.
            </p>
            <p style="margin-bottom: 5px;">
                Globally, there have been 26 human cases from Jan 2022-April 2024, and these are tracked. More
                information about this can be seen in a <a
                    href="https://cdc.gov/flu/avianflu/spotlights/2023-2024/h5n1-technical-report_april-2024.htm#:~:text=One%20human%20case%20of%20A,A(H5N1)%20virus%20infection."
                    target="_blank">technical report</a> from the CDC. The cases are a mix between different H5N1 clades
                including 2.3.2.1c and 2.3.4.4b. Most human cases have been related to individuals who are in contact
                with dead or sick poultry. There has been no reported or identified human-to-human transmission. Since
                2020, six human cases of A(H5N1) linked to the 2.3.4.4b clade have been reported to WHO. This assessment
                focuses on the latest strains of A(H5N1) from the 2.3.4.4b clade.
            </p>
            <p style="margin-bottom: 5px;">In late March 2024, a dairy farmworker experienced redness and discomfort in
                the right eye. Upon examination, subconjunctival hemorrhage and serous drainage were observed in the
                right eye, with no other symptoms. The worker had close contact with dairy cows, some exhibiting signs
                of illness consistent with HPAI A(H5N1) virus infection. Testing revealed presumptive influenza A and
                A(H5) virus in conjunctival and nasopharyngeal swab specimens. The worker was isolated at home and
                treated with oseltamivir. The next day, subconjunctival bleeding was observed in both eyes.
            </p>
            <p style="margin-bottom: 5px;">
                Further testing confirmed HPAI A(H5N1) virus infection. The virus showed genetic similarity to strains
                found in Texas dairy cattle and wild birds. Although it maintained avian characteristics, it had a
                mutation associated with adaptation to mammalian hosts. No genetic markers for antiviral drug resistance
                were found. The virus's hemagglutinin closely resembled existing candidate vaccine viruses for A(H5N1).
            </p>
        </div>
    </div>
</div>
<div class="section far2x" id="h5n1-history-section">
    <h3 class="close2x section-title"><span class="wrap">H5N1 History</span></h3>
    <p style="margin-bottom: 5px;">
        As seen in the figure below from the CDC, the global epidemic curve of H5N1 has had 909 human cases since 1997.
    </p>
    <div style="margin: 10px 0 25px 0;">
        <div style="display: flex;justify-content: center;margin-bottom: 5px;">
            <img src="/public/js/p3/resources/images/outbreaks/h5n1/human-cases-april-2024.avif"
                 style="max-width: 75%"/>
        </div>
        <blockquote style="text-align: center;max-width: 85%;margin: auto;">
            <a href="https://www.cdc.gov/flu/avianflu/spotlights/2023-2024/h5n1-technical-report_april-2024.htm#:~:text=One%20human%20case%20of%20A,A(H5N1)%20virus%20infection."
               target="_blank">CDC Epidemic Curve</a> of Human Cases of A(H5N1) by Illness Onset Date, 1997-2024 by
            Country (N=909).
        </blockquote>
    </div>
    <p>
        The CDC protocol is such that “upon detecting a virus that tests positive for influenza A but is negative for
        human H1 or H3 genes, the public health laboratory will rapidly contact CDC and ship the specimen to CDC.
        Samples that are influenza A positive but negative for human H1 or H3 genes may also be tested for H5 by state
        public health laboratories and are rapidly sent to CDC for a diagnostic result. An investigation of the case
        will be initiated, and a case report form will be submitted to CDC through the novel influenza A reporting
        module.”
    </p>
</div>
<div class="section far2x" id="influenza-a-virus-section">
    <h3 class="close2x section-title"><span class="wrap">Influenza A Virus</span></h3>
    <p style="margin-bottom: 5px;">
        Influenza A virus, a member of the Orthomyxoviridae family, is a significant etiological agent of influenza, an
        acute respiratory illness with substantial global impact. Characterized by its enveloped structure housing a
        segmented, negative-sense single-stranded RNA genome, this virus exhibits remarkable genetic plasticity,
        facilitating rapid evolutionary adaptation and strain diversification.
    </p>
    <p style="margin-bottom: 5px;">
        Preventative strategies against influenza A entail vaccination campaigns targeting prevalent strains alongside
        infection control measures emphasizing respiratory hygiene and social distancing. Therapeutic interventions,
        predominantly relying on neuraminidase inhibitors and adamantanes, aim to facilitate symptomatology and mitigate
        disease progression, particularly when administered promptly following symptom onset.
    </p>
    <p style="margin-bottom: 5px;">
        Influenza is organized into clades representing distinct evolutionary lineages within the Influenza A virus,
        characterized by genetic divergence and phylogenetic clustering. These clades arise from the continuous genetic
        reassortment and mutation inherent to the virus, leading to novel strains with unique antigenic profiles.
        Through comprehensive genomic analyses and surveillance initiatives, scientists classify influenza viruses into
        clades to track their evolutionary trajectories, assess antigenic variation, and select vaccine strains.
        Understanding the dynamics of influenza clades is paramount for predicting seasonal epidemics, anticipating
        pandemics, and developing targeted interventions to mitigate the impact of this ever-evolving viral pathogen on
        global public health.
    </p>
    <div style="margin: 10px 0 25px 0;">
        <div style="display: flex;justify-content: center;margin-bottom: 5px;">
            <img src="/public/js/p3/resources/images/outbreaks/h5n1/influenza_virion_image.svg"
                 style="max-width: 500px"/>
            <img src="/public/js/p3/resources/images/outbreaks/h5n1/segmented_linear_genome.svg"
                 style="max-width: 500px"/>
        </div>
        <blockquote style="text-align: center;max-width: 85%;margin: auto;">
            Influenza A Genomic Structure: Segmented ssRNA(-) linear genome, encapsidated by nucleoprotein (NP).
            Contains 8 segments coding for a total of 12-14 proteins depending on strains. Segment sizes range from 890
            to 2,341nt. Genome total size is 13.5Kb. See the interactive version at <a
                href="https://viralzone.expasy.org/6?outline=all_by_species" target="_blank">Viral Zone</a>.
        </blockquote>
    </div>
    <p style="margin-bottom: 5px;">
        Influenza A virus spreads efficiently via respiratory droplets, efficiently exploiting host respiratory
        epithelial cells as its primary replication site. Key to its pathogenic prowess is the virus's capacity for
        antigenic drift and shift, mechanisms by which it evades host immune surveillance, precipitating periodic
        epidemics and potential pandemics.
    </p>
    <p>
        Clinical manifestations of influenza A infection encompass a spectrum of symptoms, including fever, malaise,
        myalgia, respiratory distress, and complications such as pneumonia. The severity of disease often correlates
        with host factors, including age, immune status, and underlying health conditions.
    </p>
</div>
<div class="section far2x" id="influenza-a-tax-section">
    <h3 class="close2x section-title"><span class="wrap">Influenza A Taxonomy</span></h3>
    <ul style="list-style: none;">
        <li><b>Realm:</b> Riboviria</li>
        <li><b>Kingdom:</b> Orthornavirae</li>
        <li><b>Phylum:</b> Negarnaviricota</li>
        <li><b>Subphylum:</b> Polyploviricotina</li>
        <li><b>Class:</b> Insthoviricetes</li>
        <li><b>Order:</b> Articulavirales</li>
        <li><b>Family:</b> Orthomyxoviridae</li>
        <li><b>Genus:</b> Alphainfluenzavirus</li>
        <li><b>Species:</b> Alphainfluenzavirus influenzae</li>
        <li><b>Sub-species (of the current 2024 H5N1 outbreak):</b> H5N1, 2.3.4.4b</li>
    </ul>
</div>
<div class="section far2x" id="h-n-decoded-section">
    <h3 class="close2x section-title"><span class="wrap">H-N Decoded</span></h3>
    <p>
        Influenza A viruses are classified into subtypes based on their surface proteins: hemagglutinin (H) and
        neuraminidase (N) - for example, H5N1, H3N2, etc.
    </p>
</div>
<div class="section far2x" id="disease-information-section">
    <h3 class="close2x section-title"><span class="wrap">Disease Information</span></h3>
    <p style="margin-bottom: 5px;">
        In humans, the influenza A virus spreads efficiently via respiratory droplets, efficiently exploiting host
        respiratory epithelial cells as its primary replication site. The virus's capacity for antigenic drift and shift
        is critical to its pathogenic prowess, which evades host immune surveillance, precipitating periodic epidemics
        and potential pandemics.
    </p>
    <p style="margin-bottom: 5px;">
        Clinical manifestations of influenza A infection encompass a spectrum of symptoms, including fever, malaise,
        myalgia, respiratory distress, and complications such as pneumonia. The severity of the disease often correlates
        with host factors, including age, immune status, and underlying health conditions.
    </p>
</div>
<div class="section close2x" id="epidemiology-section">
    <h3 class="close2x section-title"><span class="wrap">Epidemiology</span></h3>
    <p style="margin-bottom: 5px;">
        Influenza is a well-studied virus, and much previous work has been done to understand and monitor mutations that
        may affect virus transmissibility, virulence, and antigenic properties, which could impact vaccine efficacy.
    </p>
    <p style="margin-bottom: 5px;">
        Influenza A viruses are of particular concern due to their ability to infect many hosts, including humans,
        birds, pigs, and other mammals. The transmission dynamics of influenza A viruses between animals and humans vary
        depending on the specific virus subtype and the characteristics of the host species involved.
    </p>
    <p style="margin-bottom: 5px;">
        Avian influenza A viruses, such as HPAI A(H5N1), primarily circulate among birds, particularly wild aquatic
        birds, which serve as natural reservoirs. Transmission to humans typically occurs through direct or close
        contact with infected poultry or contaminated environments, such as live bird markets or farms. Human infections
        with avian influenza viruses often result from exposure to respiratory secretions or feces of infected birds.
        While human-to-human transmission of avian influenza viruses is possible, it usually occurs sporadically and is
        limited in scope.
    </p>
    <p style="margin-bottom: 5px;">
        In contrast, swine influenza A viruses, such as H1N1 and H3N2, can infect pigs and humans. Transmission of swine
        influenza viruses from pigs to humans can occur through direct contact with infected pigs, inhalation of
        virus-containing aerosols, or contact with contaminated surfaces. Certain occupational groups, such as pig
        farmers and veterinarians, are at higher risk of swine influenza virus exposure.
    </p>
    <p style="margin-bottom: 5px;">
        Influenza A viruses' potential to undergo genetic reassortment in intermediate hosts, such as pigs, poses a risk
        for the emergence of novel virus strains with pandemic potential. Reassortment occurs when two different
        influenza viruses infect the same host cell and exchange genetic material, generating a new virus with a
        combination of genes from both parent viruses.
    </p>
    <p>
        Effective surveillance and control measures, including monitoring animal populations, early detection of novel
        virus strains, and implementation of biosecurity measures, are crucial for mitigating the risk of zoonotic
        transmission of influenza A viruses and reducing the likelihood of pandemic emergence. Additionally, research
        into the genetic and ecological factors influencing virus transmission between animals and humans is essential
        for improving our understanding of influenza epidemiology and informing public health interventions.
    </p>
</div>





